Kong YY, Dai B, Kong JC, et al. Subcutaneous panniculitis⁃like T⁃cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO⁃EORTC classification[J]. Am J Surg Pathol, 2008, 32(10): 1495⁃1502. DOI: 10.1097/PAS.0b013e31817a9081.
[2]
Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis⁃ like T⁃cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases[J]. Blood, 2008, 111(2): 838⁃845. DOI: 10.1182/blood⁃2007⁃04⁃087288.
Acree SC, Tovar JP, Pattengale PK, et al. Subcutaneous panniculitis⁃like T⁃cell lymphoma in two pediatric patients: an HIV⁃positive adolescent and a 4⁃month⁃old infant[J]. Fetal Pediatr Pathol, 2013, 32(3): 175⁃183. DOI: 10.3109/15513815. 2012.701264.
[5]
Velez NF, Ishizawar RC, Dellaripa PF, et al. Full facial edema: a novel presentation of subcutaneous panniculitis⁃like T⁃cell lymphoma[J]. J Clin Oncol, 2012, 30(25): e233⁃e236. DOI: 10.1200/JCO.2011.40.7684.
[6]
Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis⁃like T⁃cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature[J]. Am J Dermatopathol, 2001, 23(3): 206⁃215.
Dargent JL, Diedhiou A, Lothaire P, et al. Subcutaneous lymphoid hyperplasia arising at site of ethnic scarifications and mimicking subcutaneous panniculitis⁃like T⁃cell lymphoma[J]. Virchows Arch, 2001, 438(3): 298⁃301. DOI: 10.1007/s004280000320.
[9]
Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis⁃like T⁃cell lymphoma: a systematic analysis of 156 patients reported in the literature[J]. Cancer, 2004, 101(6): 1404⁃1413. DOI: 10.1002/cncr.20502.